SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0390 6078 OR L773:1592 8721 "

Sökning: L773:0390 6078 OR L773:1592 8721

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Abrantes, João A., et al. (författare)
  • Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients
  • 2020
  • Ingår i: Haematologica. - Ferrata Storti Foundation. - 0390-6078 .- 1592-8721. ; 105:5, s. 1443-1453
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Pharmacokinetic-based prophylaxis of replacement factor VIII products has been encouraged in the past years, but the exposure (factor VIII activity)-response (bleeding frequency) relationship remains unclear. The aim of this study was to characterize the relationship between factor VIII dose, plasma factor VIII activity, bleeding patterns and individual characteristics in severe hemophilia A patients. Pooled pharmacokinetic and bleeding data during prophylactic treatment with BAY 81-8973 (octocog alfa) were obtained from the three LEOPOLD trials. The population pharmacokinetics of factor VIII activity and longitudinal bleeding frequency, as well as bleeding severity, were described using nonlinear mixed effects modelling in NONMEM. In total, 183 patients (median age 22 years [range, 1-61]; weight 60 kg [11-124]) contributed with 1535 plasma factor VIII activity observations, 633 bleeds and 11 patient/study characteristics (median observation period 12 months [3.1-13.1]). A parametric repeated time-to-categorical bleed model, guided by plasma factor VIII activity from a 2-compartment population pharmacokinetic model, described the time to the occurrence of bleeds and their severity. Bleeding probability decreased with time of study, and a bleed was not found to affect the time of the next bleed. Several covariate effects were identified, including the bleeding history in the 12-month pre-study period increasing the bleeding hazard. However, unexplained inter-patient variability for the phenotypic bleeding pattern remained large (111%CV). Further studies to translate the model into a tool for dose individualization that considers the individual bleeding risk are required. Research based on a post-hoc analysis of the LEOPOLD studies (ClinicalTrials.gov identifiers NCT01029340, NCT01233258 and NCT01311648).</p>
  •  
2.
  •  
3.
  • Agathangelidis, Andreas, et al. (författare)
  • Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
  • 2018
  • Ingår i: Haematologica. - 0390-6078 .- 1592-8721. ; 103:5, s. 865-873
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Despite the recent discovery of recurrent driver mutations in chronic lymphocytic leukemia, the genetic factors involved in disease onset remain largely unknown. To address this issue, we per-formed whole-genome sequencing in 11 individuals with monoclonal B-cell lymphocytosis, both of the low-count and high-count subtypes, and 5 patients with ultra-stable chronic lymphocytic leukemia (&gt;10 years without progression from initial diagnosis). All three entities were indistinguishable at the genomic level exhibiting low genomic complexity and similar types of somatic mutations. Exonic mutations were not frequently identified in putative chronic lymphocytic leukemia driver genes in all settings, including low-count monoclonal B-cell lymphocytosis. To corroborate these findings, we also performed deep sequencing in 11 known frequently mutated genes in an extended cohort of 28 monoclonal B-cell lym phocytosis/chronic lymphocytic leukemia cases. Interestingly, shared mutations were detected between clonal B cells and paired polymorphonuclear cells, strengthening the notion that at least a fraction of somatic mutations may occur before disease onset, likely at the hematopoietic stem cell level. Finally, we identified previously unreported non-coding variants targeting pathways relevant to B-cell and chronic lymphocytic leukemia development, likely associated with the acquisition of the characteristic neoplastic phenotype typical of both monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.</p>
  •  
4.
  •  
5.
  • Arnold, Staci D., et al. (författare)
  • Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
  • 2017
  • Ingår i: Haematologica. - 0390-6078 .- 1592-8721. ; 102:11, s. 1823-1832
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Advances in allogeneic hematopoietic cell transplantation for sickle cell disease have improved outcomes, but there is limited analysis of healthcare utilization in this setting. We hypothesized that, compared to late transplantation, early transplantation (at age &lt; 10 years) improves outcomes and decreases healthcare utilization. We performed a retrospective study of children transplanted for sickle cell disease in the USA during 2000-2013 using two large databases. Univariate and Cox models were used to estimate associations of demographics, sickle cell disease severity, and transplant-related variables with mortality and chronic graft-versus-host disease, while Wilcoxon, Kruskal-Wallis, or linear trend tests were applied for the estimates of healthcare utilization. Among 161 patients with a 2-year overall survival rate of 90% (95% confidence interval [CI] 85-95%) mortality was significantly higher in those who underwent late transplantation versus early (hazard ratio (HR) 21, 95% CI 2.8-160.8, P=0.003) and unrelated compared to matched sibling donor transplantation (HR 5.9, 95% CI 1.7-20.2, P=0.005). Chronic graftversus host disease was significantly more frequent among those translanted late (HR 1.9, 95% CI 1.0-3.5, P=0.034) and those who received an unrelated graft (HR 2.5, 95% CI 1.2-5.4; P=0.017). Merged data for 176 patients showed that the median total adjusted transplant cost per patient was $467,747 (range: $344,029-$ 799,219). Healthcare utilization was lower among recipients of matched sibling donor grafts and those with low severity disease compared to those with other types of donor and disease severity types (P&lt;0.001 and P=0.022, respectively); no association was demonstrated with late transplantation (P=0.775). Among patients with 2-year pre-and post-transplant data (n=41), early transplantation was associated with significant reductions in admissions (P&lt;0.001), length of stay (P&lt;0.001), and cost (P=0.008). Early transplant outcomes need to be studied prospectively in young children without severe disease and an available matched sibling to provide conclusive evidence for the superiority of this approach. Reduced post-transplant healthcare utilization inpatient care indicates that transplantation may provide a sustained decrease in healthcare costs over time.</p>
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (73)
Typ av publikation
tidskriftsartikel (475)
konferensbidrag (139)
forskningsöversikt (5)
Typ av innehåll
refereegranskat (351)
övrigt vetenskapligt (307)
Författare/redaktör
Bjorkholm, M, (53)
Rosenquist, R. (41)
Rosenquist, Richard (37)
Hellstrom-Lindberg, ... (34)
Stamatopoulos, K (33)
Stamatopoulos, Kosta ... (32)
visa fler...
Nahi, H, (31)
Landgren, O, (31)
Ghia, P (28)
Kristinsson, SY, (27)
Juliusson, Gunnar, (26)
Pospisilova, S., (25)
Mansouri, Larry (24)
Turesson, Ingemar, (23)
Ljungman, P, (21)
Juliusson, G (21)
Osterborg, A, (20)
Anagnostopoulos, A., (20)
Davi, F., (20)
Samuelsson, J, (19)
Oscier, D., (19)
Baliakas, Panagiotis ... (18)
Mattsson, Mattias, (18)
Turesson, I, (17)
Karlsson, K (17)
Hadzidimitriou, A., (16)
Davis, Z., (16)
Sutton, Lesley-Ann, (16)
Jansson, M (15)
Agathangelidis, A (15)
Plevova, K., (15)
Stilgenbauer, S., (15)
Belessi, C., (15)
Birgegård, Gunnar, (14)
Hultcrantz, M, (14)
Forestier, Erik (14)
Ringden, O, (14)
Kimby, E, (14)
Sutton, L. A., (14)
Andreasson, B (13)
Ghia, Paolo, (13)
Pospisilova, Sarka (13)
Besses, C (13)
Kristinsson, Sigurdu ... (13)
Hansson, L, (12)
Remberger, M (12)
Stalika, E., (12)
Panagiotidis, P., (12)
Sutton, LA, (12)
Harrison, C (12)
visa färre...
Lärosäte
Karolinska Institutet (330)
Uppsala universitet (138)
Lunds universitet (103)
Umeå universitet (37)
Linköpings universitet (24)
Göteborgs universitet (15)
visa fler...
Kungliga Tekniska Högskolan (6)
Örebro universitet (6)
Stockholms universitet (2)
visa färre...
Språk
Engelska (616)
Spanska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (313)
Naturvetenskap (3)
Lantbruksvetenskap (2)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy